Compare two pneumococcal vaccines in adults treated for lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial compares two vaccination plans to see which one works better for preventing pneumococcal infections after lymphoma chemotherapy. You may be randomly assigned to one of the vaccine strategies, and the study checks your immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are followed in a hematology clinic and are a lymphoma patient
- You have received your first round of chemotherapy for diffuse large B cell lymphoma or follicular lymphoma
- You can expect to live more than 6 months, and you can give consent
- You have health insurance (and if pregnancy is possible, you have a negative pregnancy test and use contraception)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a series of two pneumococcal vaccines (PCV20 and PPSV23) in people with CLL-related immune weakness. It aims to see how well the vaccines work and how safe they are for preventing serious lung infections.
This Phase 2 study tests a specific plan for giving a pneumococcal vaccine in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It may help improve protection against pneumococcal infections in patients who have not started CLL/SLL treatment yet.
This study looks at whether a pneumonia vaccine can help people with lung cancer. You can join no matter what stage your cancer is or what treatments you've had, as long as you haven't had this vaccine before.
This study measures how well certain vaccines stimulate the immune system in people with B-cell blood cancers such as CLL and different types of lymphoma or Waldenström macroglobulinemia. It may help doctors better predict who will benefit most from vaccination and improve vaccine planning for these conditions.
This trial studies how well the pneumonia vaccine works in people with esophageal or liver cancer who have low white blood cell counts after chemoradiation. It aims to see if the vaccine can still protect them from infection.
This study tests a new pneumococcal vaccine (PCV26) for safety in adults 60 and older. It aims to find out if the vaccine is safe and how the body responds to it.
Hear when a new Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.